Formulari Ubat KKM (FUKKM)

# Generic Name MDC Category Indications Dosage
31 Alfacalcidol 0.25 mcg Capsule A11CC03000C1001XX A/KK i) Renal osteodystrophy in patients on haemodialysis ii) Hypoparathyroidism and pseudohypoparathyroidism iii) Adjunct to the management of tertiary hyperparathyroidism iv) Rickets and osteomalacia v) Osteoporosis Initial dose ADULT and CHILD above 20kg body weight : 1 mcg daily; CHILD under 20kg body weight : 0.05 mcg/kg/day. Maintenance dose : 0.25 mcg to 2 mcg daily
32 Alfacalcidol 1 mcg Capsule A11CC03000C1002XX A/KK i) Renal osteodystrophy in patients on haemodialysis ii) Hypoparathyroidism and pseudohypoparathyroidism iii) Adjunct to the management of tertiary hyperparathyroidism iv) Rickets and osteomalacia v) Osteoporosis Initial dose ADULT and CHILD above 20kg body weight : 1 mcg daily; CHILD under 20kg body weight : 0.05 mcg/kg/day. Maintenance dose : 0.25 mcg to 2 mcg daily
33 Alfacalcidol 2 mcg/ml Drops A11CC03000D5001XX A* i) Renal osteodystrophy in patients on haemodialysis ii) Hypoparathyroidism and pseudohypoparathyroidism iii) Adjunct to the management of tertiary hyperparathyroidism iv) Rickets and osteomalacia v) Osteoporosis NEONATES : 0.1 mcg/kg/day
34 Alfacalcidol 2 mcg/ml Injection A11CC03000P3001XX A* Treatment of: i) Renal osteodystrophy in patients on haemodialysis ii) Hypoparathyroidism and pseudohypoparathyroidism iii) Adjunct to the management of tertiary hyperparathyroidism iv) Rickets and osteomalacia v) Osteoporosis Adult: Initially, 1 mcg daily. Maintenance: 0.25-1 mcg daily. Child: Premature infants and neonates: 0.05-0.1 mcg/kg daily; <20 kg: 0.05 mcg/kg daily. Elderly: 0.5 mcg daily.
35 Alfentanil HCl 0.5 mg/ml Injection N01AH02110P3001XX A* For use as short acting narcotic analgesic in short procedures and day-care surgical procedures Initial dose: 20 - 40 mcg/kg. Supplemental dose: 15 mcg/kg or infusion 0.5 - 1.0 mcg/kg/min
36 Alfuzosin HCl 10 mg Tablet G04CA01110T1001XX A* Treatment of functional symptoms related with benign prostatic hypertrophy (BPH) 10 mg once a day pre bed
37 Alglucosidase alfa 5 mg/ml Injection A16AB07000P4001XX A* Infantile-onset Pompe disease 20 mg/kg of body weight administered once every 2 weeks as an intravenous infusion. Monitoring It is suggested that patients be monitored periodically for IgG antibody formation. Patients who experience Infusion-associated reactions suggestive of hypersensitivity may be tested for IgE antibodies to alglucosidase alfa. Treated patients who experience a decrease in benefit despite continued treatment with Alglucosidase Alfa, in whom antibodies are suspected to play a role, may be tested for neutralization of enzyme uptake or activity.
38 Alkaline Nasal Douche R01A000999L5001XX B To remove nasal plug To be diluted with an equal volume of warm water before use
39 All-Trans Retinoic Acid 10 mg Capsule L01XX14000C1001XX A* Acute promyelocytic leukaemia Induction: 45 mg/m2 daily for 30 - 90 days. Maintenance: 45 mg/m2 daily for 2 weeks every 3 months. Renal/or hepatic insufficiency: 25mg/m2 daily for 30-90 days. Refer to protocols
40 Allopurinol 100 mg Tablet M04AA01000T1002XX A/KK i) Frequent and disabling attacks of gouty arthritis (3 or more attacks/year). ii) Clinical or radiographic signs of erosive gouty arthritis. iii) The presence of tophaceous deposits. iii) Urate nephropathy. iv) Urate nephrolithiasis. v) Impending cytotoxic chemotherapy or radiotherapy for lymphoma or leukaemia Initial dose : 100-300 mg daily. Maintenance : 300-600 mg daily. Maximum: 900 mg daily
41 Allopurinol 300 mg Tablet M04AA01000T1001XX A/KK i) Frequent and disabling attacks of gouty arthritis (3 or more attacks/year). ii) Clinical or radiographic signs of erosive gouty arthritis. iii) The presence of tophaceous deposits. iii) Urate nephropathy. iv) Urate nephrolithiasis. v) Impending cytotoxic chemotherapy or radiotherapy for lymphoma or leukaemia Initial dose : 100-300 mg daily. Maintenance : 300-600 mg daily. Maximum: 900 mg daily
42 Alprazolam 0.25 mg Tablet N05BA12000T1001XX A/KK Anxiety disorders 0.25 - 0.5 mg 3 times daily (elderly or delibitated 0.25 mg 2-3 times daily), increased if necessary to a total dose of 3 mg/day. Not recommended for children
43 Alprazolam 0.5 mg Tablet N05BA12000T1002XX A Anxiety disorders 0.25 - 0.5 mg 3 times daily (elderly or delibitated 0.25 mg 2-3 times daily), increased if necessary to a total dose of 3 mg/day. Not recommended for children
44 Alprazolam 1 mg Tablet N05BA12000T1003XX A Anxiety disorders 0.25 - 0.5 mg 3 times daily (elderly or delibitated 0.25 mg 2-3 times daily), increased if necessary to a total dose of 3 mg/day. Not recommended for children
45 Alprostadil 500 mcg/ml Injection C01EA01000P3001XX A* For treatment of congenital heart diseases which are ductus arteriosus dependent 0.05 - 0.1 mcg/kg/min by continuous IV infusion, then decreased to lowest effective dose
46 Alteplase 50 mg per vial Injection B01AD02000P4001XX A* Thrombolytic treatment of acute ischaemic stroke. 0.9 mg/kg (maximum of 90 mg) infused over 60 minutes with 10% of the total dose administered as an initial intravenous bolus. Treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging technique.
47 Amantadine HCl 100 mg Capsule N04BB01110C1001XX B Parkinson's disease Initial dose: 100 mg daily and is increased to 100 mg twice daily (not later than 4 p.m.) after a week. Elderly over 65 years: less than 100 mg or 100 mg at intervals of more than 1 day
48 Amikacin 125 mg/ml Injection J01GB06183P3003XX A Infections due to susceptible organisms ADULT: (IM or IV): 15 mg/kg/day 8 - 12 hourly for 7 - 10 days. Maximum: 1.5 g/day. CHILD: 15 mg/kg/day 8 - 12 hourly. Maximum: 1.5 g/day. Neonates: Initial loading dose of 10 mg/kg followed by 7.5 mg/kg/day 12 hourly. Maximum 15mg/kg/day
49 Amikacin 250mg/ml Injection J01GB06183P3002XX A Infections due to susceptible organisms ADULT: (IM or IV): 15 mg/kg/day 8 - 12 hourly for 7 - 10 days. Maximum: 1.5 g/day. CHILD: 15 mg/kg/day 8 - 12 hourly. Maximum: 1.5 g/day. Neonates: Initial loading dose of 10 mg/kg followed by 7.5 mg/kg/day 12 hourly. Maximum 15mg/kg/day
50 Amiloride HCl 5 mg & Hydrochlorothiazide 50 mg Tablet C03EA01900T1001XX B i) Diuretic as an adjunct to the management of oedematous states ii) Hypertension i) Initially 1 - 2 tab daily adjusted according to response. Max : 4 tabs daily. ii) 1 -2 tabs daily as a single or divided dose
51 Amino Acids Injection B05BA01910P3001XX A Source of amino acids in patients needing IV nutrition Dose to be individualised. ADULT usually 500-2000 ml by IV. ADULT usual requirement for amino acid: 1-2 g/kg/day
52 Amino Acids with Electrolytes Injection B05BA10910P3002XX A Source of amino acids and electrolytes in patients needing IV nutrition Dose to be individualised. ADULT usual requirement for amino acid 1-2 g/kg/day
53 Amino Acids with Glucose with Electrolytes Injection B05BA10910P3003XX A Source of amino acids, carbohydrate and electrolytes in patients needing IV nutrition Dose to be individualised. ADULT usual requirement for amino acid 1-2 g/kg/day, carbohydrate 4-6 g/kg/day
54 Amino Acids, Glucose and Lipid with Electrolytes Injection B05BA10910P3001XX A Source of amino acids, carbohydrate, lipid and electrolytes in patients needing IV nutrition Dose to be individualised. ADULT: 500 - 2000 ml daily given by IV. ADULT usual requirement for amino acid 1-2 g/kg/ day, carbohydrate 4-6 g/kg/day, lipid 2-3 g/kg/day
55 Aminophylline 25 mg/ml Injection R03DA05000P3001XX B Reversible airways obstruction, acute severe brochospasm Adult: Loading dose: 5 mg/kg (ideal body weight) or 250-500 mg (25 mg/ml) by slow inj or infusion over 20-30 min. Maintenance infusion dose: 0.5 mg/kg/hr. Max rate: 25 mg/min. Child: Loading dose: same as adult dose. Maintenance dose: 6 mth-9 yr: 1 mg/kg/hr and 10-16 yr: 0.8 mg/kg/hr.
56 Amiodarone 200 mg Tablet C01BD01110T1001XX A* Arrhythmias 200 mg 3 times daily for 1 week, then reduced to 200 mg twice daily for another week. Maintenance dose, usually 200 mg daily or the minimum required to control the arrhythmia
57 Amiodarone 50 mg/ml Injection C01BD01110P3001XX A* Arrhythmias when other drugs are contraindicated or ineffective Initial infusion of 5mg/kg via large venous access over 20-120 minutes with ECG monitoring; subsequent infusion given if necessary according to response up to a maximum of 1.2 g in 24 hours
58 Amisulpride 100 mg Tablet N05AL05000T1001XX A* Treatment of psychoses, particularly acute or chronic schizophrenia disorders characterized by positive symptoms(e.g. delusion, hallucinations, thought disorders) and/or negative symptoms(e.g. blunted emotions, emotional and social withdrawal) including when the negative symptoms predominate Predominantly negative episodes: 50-300 mg once daily adjusted according to the patient?s response. Mixed episodes with positive and negative symptoms: 400-800 mg/day in 2 divided doses adjusted according to the patient?s response. Should be taken on an empty stomach (Preferably taken before meals)
59 Amisulpride 400 mg Tablet N05AL05000T1002XX A* Treatment of psychoses, particularly acute or chronic schizophrenia disorders characterized by positive symptoms(e.g. delusion, hallucinations, thought disorders) and/or negative symptoms(e.g. blunted emotions, emotional and social withdrawal) including when the negative symptoms predominate Predominantly negative episodes: 50-300 mg once daily adjusted according to the patient?s response. Mixed episodes with positive and negative symptoms: 400-800 mg/day in 2 divided doses adjusted according to the patient?s response. Should be taken on an empty stomach (Preferably taken before meals)
60 Amitriptyline HCl 25 mg Tablet N06AA09110T1001XX B Depression Initially 25mg 3 times a day. Maintenance: 25-100mg daily in divided doses. Hospitalized patient: 100mg/day &gradually increase to 200-300mg/day. ADOLESCENT and ELDERLY: initially 20-30mg/day in divided doses w/ gradual increments. CHILD under 16 years are not recommended

Halaman-halaman